FDA finalizes guidance on adjusting for covariates in randomized trials

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy